SCHEMBL21395909

SCHEMBL21395909

N#Cc1ccc(-c2ccc3oc4ccc(-c5cc6cccnc6c6ncccc56)cc4c3c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.40
MAP4K4 O95819 1/20 0.39
CCR1 P32246 2/20 0.39
CCR8 P51685 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
TNKS O95271 1/20 0.38
PARP1 P09874 1/20 0.37
FABP1 P07148 1/20 0.37
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36
CYP11B2 P19099 3/20 0.36
HRH3 Q9Y5N1 1/20 0.35
MAPT P10636 1/20 0.35
GLO1 Q04760 1/20 0.35
PDE4D Q08499 3/20 0.35
PDE4A P27815 1/20 0.35
PDE4C Q08493 1/20 0.35
CYP11B1 P15538 2/20 0.34
CYP17A1 P05093 1/20 0.34
LIMK1 P53667 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21396190 1.00 PGR (0.40) PGRMAP4K4CCR1CCR8L3MBTL1
SCHEMBL21396192 0.98 PGR (0.40) PGRMAP4K4CCR1CCR8L3MBTL1
SCHEMBL21395908 0.91 CLK4 (0.46) PGRMAP4K4ALDH1A1KDM4EPDE4D
SCHEMBL21396131 0.91 CCR1 (0.37) PGRMAP4K4CCR1CCR8L3MBTL1
SCHEMBL31285974 0.88 CCR1 (0.49) CCR1CCR8L3MBTL1ALDH1A1KDM4E
SCHEMBL16697977 0.88 CCR1 (0.49) CCR1CCR8L3MBTL1ALDH1A1KDM4E
SCHEMBL23331492 0.84 MAPT (0.46) CCR1CCR8L3MBTL1ALDH1A1KDM4E
SCHEMBL21395980 0.84 PIM1 (0.39) MAP4K4CCR1CCR8L3MBTL1PARP1
SCHEMBL20726920 0.82 ABCG2 (0.43) CCR1CCR8L3MBTL1PARP1FABP1
SCHEMBL20726714 0.82 ABCG2 (0.44) CCR1CCR8L3MBTL1PARP1FABP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190292169-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190292169-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME LAGE3, PPOX, SUN2 PGR 1369/4885MAP4K4 3481/4885CCR1 4251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.